학술논문

1645P STAT3, ACTA2, and SPARC stromal markers predict response to Gemcitabine/Cisplatin/Nab-paclitaxel (GCN) in patients with advanced pancreatic adenocarcinoma (apdac)
Document Type
Abstract
Source
In Annals of Oncology October 2023 34 Supplement 2:S908-S909
Subject
Language
ISSN
0923-7534